Top in endocrinology: Improving health outcomes in diabetes; uterine fibroid disparities
Click Here to Manage Email Alerts
A presenter at the Cardiometabolic Health Congress reported that eating smaller portion sizes of starchy foods and increasing intake of non-starchy vegetables and whole foods can improve health outcomes in patients with diabetes.
“We don’t want people with diabetes to die of heart disease and that’s the No. 1 cause of death in this patient population,” Alison Evert, MS, RDN, CDES, FADCES, said during the presentation. “My shameless recommendation is to refer your patient to a dietetic professional who may have time to help your patients to come up with a game plan [for an individualized eating pattern].”
This was the top story in endocrinology last week.
Another top story was about how interactions between race and endocrine-disrupting chemicals may influence uterine fibroid disparities. According to researchers, Black women had 2.88 higher adjusted odds of uterine fibroids compared with white women.
Read these and more top stories in endocrinology below:
Reduce carbohydrate intake, focus on quality to improve health outcomes in diabetes
Reducing overall carbohydrate intake and eating more non-starchy vegetables and whole foods can help improve health outcomes for people with diabetes, according to a speaker at the Cardiometabolic Health Congress. Read more.
Endocrine-disrupting chemicals, race may influence uterine fibroid disparities
Interactions between endocrine-disrupting chemicals and race may affect the elevated incidence of uterine fibroids among Black women, according to study results. Read more.
Polycystic ovary syndrome may lead to greater cognitive decline later in life
Women with polycystic ovary syndrome may be more likely to have cognitive decline and reductions in white brain matter integrity than those without PCOS, according to a presenter. Read more.
Finerenone may lower risks for pneumonia, COVID-19 in adults with type 2 diabetes and CKD
Adults with type 2 diabetes and chronic kidney disease using the nonsteroidal mineralocorticoid receptor antagonist finerenone have lower risks for pneumonia and COVID-19, according to findings published in JAMA Network Open. Read more.
Spinal cord stimulation advances therapy for painful diabetic peripheral neuropathy
Diabetic peripheral neuropathy is a debilitating, progressive neurologic disorder that affects about 30% of adults with diabetes. Spinal cord stimulation is a newer option for addressing moderate to severe pain related to the condition. Read more.